|
Mr. Edward H. Myles joined Pressure BioSciences in April, 2006 as Vice President of Finance and CFO and was promoted to Senior Vice President of Finance and CFO in February, 2007. Prior to joining Pressure BioSciences, Inc., Mr. Myles served as the controller for EMD Pharmaceuticals, a wholly-owned affiliate of Merck KGaA. At EMD, Mr. Myles held a wide variety of responsibilities in the areas of accounting and licensing and business development. Prior to EMD Pharmaceuticals, Mr. Myles worked in the health care investment banking group of SG Cowen Securities. Mr. Myles was the Corporate Controller of Boston Biomedica, Inc. and also held positions of increasing responsibility at the public accounting firms of Price Waterhouse LLP and Coopers & Lybrand LLP. Mr. Myles became a CPA in 1996, and earned a BSBA, with honors, in accounting and finance from the University of Hartford, and an MBA from Washington University in St. Louis. | 